drugset / Trial / NCT01843023
Extended Release Naltrexone for Opioid-Dependent Youth
Phase 4
Completed
288 enrolled
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare 6-month treatment outcomes for 15-21 year old opioid-dependent youth receiving extended release naltrexone (XR-NTX) v. Treatment as Usual (TAU).
Timeline
- Start
- 2013-06
- Primary completion
- 2018-01-31
- Completion
- 2019-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Buprenorphine | Other / unclassified | 12 mg | — |
| Comparator | Buprenorphine | Other / unclassified | 20 mg | — |
| Subject | Naltrexone | Small molecule | 380 mg | Intramuscular |